Supplemental Data: Low bone mineral density in early pubertal transgender/gender diverse youth: Findings from the Trans Youth Care Study

  • Janet Y. Lee (Creator)
  • Courtney Anne Finlayson (Creator)
  • Johanna Olson-Kennedy (Creator)
  • Robert Garofalo (Creator)
  • Y. M. Chan (Creator)
  • David V. Glidden (Creator)
  • Stephen M. Rosenthal (Creator)
  • Stephen M. Rosenthal (Creator)

Dataset

Description

Context. Transgender youth may initiate gonadotropin-releasing hormone agonists (GnRHa) to suppress puberty, a critical period for bone-mass accrual. Low bone mineral density (BMD) has been reported in late-pubertal transgender girls prior to gender-affirming therapy, but little is known about BMD in early-pubertal transgender youth. Objective. To describe BMD in early-pubertal transgender youth. Design. Cross-sectional analysis of the prospective, observational, longitudinal Trans Youth Care Study cohort. Setting. Four multi-disciplinary academic pediatric gender centers in the United States. Participants. Early-pubertal transgender youth initiating GnRHa. Main Outcome Measures. Areal and volumetric BMD Z-scores. Results. Designated males at birth (DMAB) had below-average BMD Z-scores when compared with male reference standards, and designated females at birth (DFAB) had below-average BMD Z-scores when compared with female reference standards except at hip sites. At least one BMD Z-score was < -2 in 30% of DMAB and 13% of DFAB. Youth with low BMD scored lower on the Physical Activity Questionnaire for Older Children than youth with normal BMD, 2.32 ± 0.71 vs. 2.76 ± 0.61 (p = 0.01). There were no significant deficiencies in vitamin D, but dietary calcium intake was suboptimal in all youth. Conclusions. In early-pubertal transgender youth, BMD was lower than reference standards for sex designated at birth. This lower BMD may be explained, in part, by suboptimal calcium intake and decreased physical activity – potential targets for intervention. Our results suggest a potential need for assessment of BMD in pre-pubertal gender-diverse youth and continued monitoring of BMD throughout the pubertal period of gender-affirming therapy.
Date made availableAug 25 2020
PublisherDryad

Cite this